Project Grant R21CA301093
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$245K
Federal Agency
National Cancer Institute
Federal Grant Program
93.394
Assistance Type
Project Grant
Place of Performance
Delaware, USA
Similar Awards
This $256,000 National Science Foundation Project Grant under the Engineering (47.041) program will support the development of an artificial intelligence-based system for analyzing multiparametric magnetic resonance imaging (MRI) scans to detect prostate lesions. The awardee, Taurus Diagnostics, Inc., will create a novel prostate cancer diagnostic platform leveraging artificial intelligence image analysis for high sensitivity and specificity. Key objectives include developing methods to...
This $680,433 Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to apply cutting-edge spatial proteogenomic technologies and pathology artificial intelligence (PAI) analysis to improve prognostic estimation and understand the underlying biology driving AI outcomes in prostate cancer. The key objectives are to: 1) examine the relationships between established genomic tests and PAI scores in predicting...
This $704,563 Project Grant awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) focuses on developing quantitative MRI (qMRI) tools and an automated prostate cancer tumor segmentation method to improve identification of clinically significant prostate tumors for radiation therapy treatment planning. The project aims to build a qMRI toolset including magnetic resonance fingerprinting, arterial spin labeling, and diffusion-weighted MRI to generate 3D...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), provides $717,667 to the Icahn School of Medicine at Mount Sinai to develop an Artificial Intelligence (AI)-enabled, stroma-weighted automated grading system (SWAG) to improve risk stratification and early detection of lethal prostate cancer phenotypes in Black men. The key products and services to be delivered through this 5-year project include: Developing...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) provides $598,046 to Case Western Reserve University to develop a rapid and reproducible Magnetic Resonance Fingerprinting (MRF) method to more accurately characterize prostate tissue in the peripheral zone. The goal is to quantify key MRI parameters, including T1, T2, and diffusion, to better identify clinically significant prostate cancer and limit...
This Project Grant award from the National Cancer Institute (NCI), under CFDA Program 93.394 "Cancer Detection and Diagnosis Research", aims to develop an MRI-guided robotic system for personalized, minimally invasive prostate cancer surgery. The $607,131 award will enable the following key products and services: Creation of an MRI-guided robotic system that integrates a low-field MRI scanner and a novel robotic platform with tentacle-like manipulators to enable precise, targeted...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) provides $568,151 to develop a novel photoacoustic imaging platform for improved detection and characterization of prostate cancer aggressiveness. The project aims to optimize biocompatible photoacoustic contrast agents to enable sensitive tumor detection and quantify clinically relevant imaging biomarkers reflecting the prostate gland microarchitecture and...
This Project Grant award from the National Institutes of Health (CFDA 93.310, Trans-NIH Research Support) provides $453,000 to the University of California, Irvine to develop novel methods and algorithms for explainable deep learning models that can perform virtual H&E staining, prostate tumor segmentation, and immunohistochemistry (IHC) expression pattern analysis on digital prostate biopsy images. The goal is to generate an open-source software toolkit that can provide pixel-level...
This $435,827 Project Grant from the National Cancer Institute (NCI) under the CFDA 93.394 Cancer Detection and Diagnosis Research program supports research conducted by New York University (NYU) School of Medicine to develop deep learning methods for analyzing mass spectrometry imaging (MSI) data. The goal is to make MSI data more accessible to existing machine learning workflows by expanding the dimensionality of the data structure to treat each metabolite or lipid as an individual "color...
The National Cancer Institute (NCI) awarded a $570,634 Project Grant (CFDA 93.394 - Cancer Detection and Diagnosis Research) to the University of Connecticut to develop an advanced artificial intelligence-based computer-aided detection (AI-CAD) system for enhancing breast cancer screening. The overarching goal is to optimize and personalize breast cancer screening by advancing AI algorithms that can leverage longitudinal data, including prior mammograms and clinical risk factors, to improve...